Effects of chemopreventive agents on biomarkers related to lung tumorigenesis: alterations in 'at risk' histologically normal lung and lung lesions

Ended Awarded Last action

Contract number
HHSN26100004
Awardee
Awarding agency
Obligated
$611,204

Award facts

Opportunity
Contract value 100% obligated
$611,204.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19111, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 5 -$3,831
Close Out 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 · Of chemopreventive agents on biomarkers related to lung tumorigenesis: alterations in 'at risk' histologically normal lung and lung lesions;… $0
Original award $615,035

Quick answers

Who was awarded contract HHSN26100004?

HHSN26100004 was awarded to The Institute For Cancer Research by National Cancer Institute (National Institutes of Health) on September 18, 2013.

How much is contract HHSN26100004 worth?

The government has obligated $611,204 on HHSN26100004.

Is contract HHSN26100004 an order under another contract?

Yes. HHSN26100004 is a delivery order under HHSN261201200015I, an indefinite delivery contract, on Preclinical Efficacy and Intermediate Endpoint Biomarkers.

Was contract HHSN26100004 competed?

The extent of competition for HHSN26100004 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login